NCT00479323View on ClinicalTrials.gov

Pneumococcal Reference Standard

PHASE1CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

Pneumovax 23

Licensed pneumococcal vaccine (Pneumovax 23).

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00479323 - Pneumococcal Reference Standard | Biotech Hunter | Biotech Hunter